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Abstract
BK virus nephropathy is not an infrequent complication of renal transplantation associated with high
rates of graft loss. Although antibodies against SV40 antigen detect different viruses of the
polyomavirus family, immunohistochemistry is widely used to confirm the diagnosis of BK virus
nephropathy in renal biopsies. Here we aimed to validate the novel silver-enhanced in situ hybridization
(SISH) technique for the automated detection of BK virus in renal transplant biopsies. Two different
patient cohorts were included. Twenty-nine consecutive patients suspicious for BK virus infection were
investigated by SISH and chromogenic in situ hybridization. An additional 26 renal biopsies positive by
SV40 immunohistochemistry from 19 patients were analyzed by SISH. Polyomavirus DNA serum
levels, as determined by nested PCR analysis, were available for all of these patients. The presence of
BK virus DNA in renal tubular cells was identified in 5 of the suspicious cases by both, SISH and
chromogenic in situ hybridization . One additional patient was only positive in the SISH. In the second
cohort, SISH was positive in all SV40 positive biopsies, but SISH signals were less extensive than SV40
immunohistochemistry. Our results show that the BK virus SISH is an ancillary tool for the detection of
polyomavirus DNA in renal biopsies using bright-field microscopy. However, its diagnostic value in
comparison with standard immunohistochemistry seems to be limited.
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BK virus nephropathy is not an infrequent complication of renal transplantation associated with 
high rates of graft loss. Although antibodies against SV40 antigen detect different viruses of the 
polyomavirus family, immunohistochemistry is widely used to confirm the diagnosis of BK virus 
nephropathy in renal biopsies. We here aimed to validate the novel silver-enhanced in situ 
hybridization (SISH) technique for automated detection of BK virus in renal transplant biopsies. 
Two different patient cohorts were included. Twenty-nine consecutive patients suspicious for 
BK-virus infection were investigated by SISH and chromogenic in situ-hybridization (CISH). 
Additional 26 renal biopsies positive by SV40 immunohistochemistry from 19 patients were 
analyzed by SISH. Polyomavirus DNA serum levels as determined by nested PCR analysis were 
available for all of these patients. 
Presence of BK virus DNA in renal tubular cells was identified in five of the suspicious cases by 
both, SISH and CISH. One additional patient was only positive in the SISH. In the second cohort, 
SISH was positive in all SV40 positive biopsies, but SISH signals were less extensive than SV40 
immunohistochemistry.  
Our results demonstrate that BK virus SISH is an ancillary tool for the detection of polyomavirus 
DNA in renal biopsies using bright-field microscopy. However, its diagnostic value in 
comparison to standard immunohistochemistry seems to be limited.  
 
 






BK-, JC- and Merkel cell-polyomavirus belong to the human polyomavirus family. In 1995, BK 
virus nephropathy has been described as cause of polyomavirus-associated nephropathy (PVAN) 
in renal transplant recipients.1 Other BK virus associated urological complications include 
ureteral obstruction, hemorrhagic cystitis and hydronephrosis.2 In renal transplant patients, the 
prevalence rate of PVAN varies from 1-10%.3 In earlier years a functional decline of renal 
allografts due to PVAN occurred in 60% to 90% of cases.1, 4-6 Nowadays, early diagnosis and 
timely reduction in immunosuppression lead to preservation of graft function.6-9 Reduction of 
immunsuppression implies a higher risk of rejection due to the lowered immunosuppression. To 
avoid consequences and side effects of therapy, the diagnosis of a PVAN is of utmost clinical 
importance.  
 
Primary infection with BK virus occurs via droplets during childhood and is clinically either 
unapparent or unspecific. Following the primary infection, the virus remains intracellular in a 
latent state in renal tubular and urothelial cells.10 Eighty percent of adults have antibodies against 
BK or JC virus. In immunocompetent individuals, reactivation of the virus is usually 
asymptomatic.11 Meanwhile, reactivation is more frequent and clinically important in 
immunocompromised patients. The diagnosis of PVAN in renal biopsies is essential to reliably 
exclude other causes of a decline in renal function such as allograft rejection, drug toxicity, and 
infection with other viruses including other polyomaviruses (JC virus) but also Herpes simplex 





The current “gold standard” for the diagnosis of PVAN requires light microscopic detection of 
the characteristic virus-induced tubular changes in a renal biopsy.13 Diagnostic confirmation of 
the infected tubular epithelial cells can be achieved by polymerase chain reaction or by 
immunohistochemistry with antibodies directed against SV40. The latter is possible due to high 
homology between SV40 antigen (present in kidneys of monkeys) with BK and JC-virus in 
humans.14 
 
Virus screening tests, especially the detection of so called decoy cells (virus-infected cells with 
nuclear inclusions) in the patients’ urine or polymerase chain reaction (PCR)-based virus 
detection in the blood plasma, help to identify patients at risk for PVAN.15 Although both 
methods have high sensitivity rates, the latter one outbalanced the mere morphology-based one in 
terms of specificity and positive predictive value.15  
 
In situ-hybridization technologies, such as chromogenic in situ-hybridization (CISH) have been 
developed for DNA detection using bright field microscopy in a setting familiar to all 
histopathologists. Recently, a novel high-sensitivity in situ-hybridization technique based on 
enzymatic metallography and metallic silver deposition (silver in situ hybridization; SISH) has 
been developed for HER2 gene testing in breast cancer and other tumor entities.16-24 This method 
is fully automated, ensuring consistency of methodology and results. In this study, we determined 
the reliability of SISH to identify BK-virus DNA in kidney transplant biopsy specimens. Our 
results suggest that BK virus SISH is an ancillary tool for the detection of BK virus DNA in renal 





Materials and Methods 
 
Patients 
Two different cohorts of kidney transplant patients were examined. The first cohort included 29 
kidney transplant biopsies from the archives of the Institute for Pathology, Cleveland Clinic,  
Ohio. These cases were either demonstrating suspicious nuclear inclusions by light microscopy or 
were clinically suspicious for PVAN. BK-virus infection was determined in parallel by 
chromogenic in situ-hybridization (CISH) and silver in situ hybridization (SISH). 
The second cohort included 26 renal biopsies from 19 patients. These biopsies were retrieved 
from the archives of the Institute of Surgical Pathology Zurich between 2001 and 2008. Sixteen 
patients were men, 3 women, the median patient age was 42 years (range 15 to 66 years). Time 
after transplantation was 14 months (range 1.2 to 98 months). Diagnosis of BK-virus nephropathy 
was confirmed by SV40 immunohistochemistry. Serum levels for BK-virus as determined by 
nested PCR analysis were available in all of these patients. 
 
Staining procedures: Silver enhanced in situ hybridisation (SISH) 
The recently developed SISH technology for the detection of HER2 signals in breast cancer was 
adopted for identification of BK virus DNA in renal biopsies. A plasmid containing the complete 
BK-virus (BKV) genome (pBKV (35-1) was obtained from the American Type Culture 
Collection (ATCC catalog number 45026). BK virus DNA was released from the vector, 
pBR322, by digestion with BamHI. After agarose gel electrophoresis the BKV DNA was excised 
from the gel and purified. Double digestion with AluI and DpnI was followed by exposure to T4 
DNA polymerase in the presence of dATP, dTTP, dCTP and dGTP to render the ends flush. 




generate concatenated permuted BKV DNA. This product was subjected to repeated sequential 
amplification using random hexamer primers (terminated by 2 phosphorothioates at the 3’ end) to 
generate milligram quantities of DNA. This amplification product was labeled with DNP 
(dinitrophenol) by the MIRUS  Label IT kit (catalog number MIR3800). The resulting labeled 
DNA was used as a probe on the Ventana Benchmark XT. Following a pretreatment with 
protease2 for four minutes, probe and target tissue were codenaturated at 90°C for 8 minutes. 
After this followed the hybridization for one hour at 37°C. One drop of the custom-made BK 
virus probe was applied (2.5 ng/μl). After several stringency washes at 37°C the slide was 
incubated with SISH DET HRP complex for 2 hours. For detection one drop of SilverA, SilverB 
and SilverC was added. The chemistry of the SISH reaction, briefly described, is driven by the 
sequential addition of silver A (silver acetate), silver B (hydroquinone), and silver C (H2O2). 
Here, the silver ions (Ag+) are reduced by hydroquinone to metallic silver atoms (Ag). This 
reaction is fuelled by the substrate for horseradish-peroxidase, hydrogen-peroxidase (silver C). 
The silver precipitation is deposited in the nuclei and a single copy of the BK-virus is visualized 
as a black dot. The specimen is then counterstained with Ventana hematoxylin 2 for interpretation 
by light-microscopy. The SISH technique is illustrated in Figure 1.  
 
Staining procedures: Chromogenic in situ hybridisation (CISH) 
Unstained paraffin sections of formalin fixed renal biopsy tissue were evaluated by automated in 
situ hybridization (Discovery XT; Ventana Medical Systems, Tucson, AZ, USA) as previously 
decribed.25 Pretreatment, denaturation and hybridization were equal to the BK virus SISH as 
described above. After several stringency washes at 37°C detection was via streptavidin alkaline 
phosphatase and NBT/BCIP. The BK virus probe was a biotin labeled genomic probe (Enzo; 




probe/target denaturation and hybridization, duplex detection, stringency washing, and 
counterstaining with nuclear fast red, were automated,.25 The slides were mounted as permanent 
preparations using Cytoseal (Richard-Allan Scientific; Kalamazoo), and evaluated using 
conventional bright field microscopy.  
 
Staining procedures: SV40 Immunohistochemistry 
Immunohistochemistry was conducted with the Ventana Benchmark automated staining system 
(Ventana Medical Systems, Tucson, AZ) and with Ventana reagents. For the SV40 
immunohistochemistry we used the mouse monoclonal antibody (PAb416, Abcam plc, 
Cambridge, UK, dilution 1:600). Primary antibodies were detected using the UltraVIEW DAB 
detection kit after heat-induced epitope retrieval. The slides were counterstained with 
hematoxylin, dehydrated and mounted. 
 
Scoring Criteria 
SISH and CISH of the Cleveland cohort were analyzed by one pathologist (RT). For the Zurich 
cohort, SISH signals and SV40 immunohistochemistry were evaluated by two pathologists (FRF; 
AG). Percentage of tubules with positive cells were scored using a four-tired approach (negative: 
0%, weak: 1-25%, moderate: 26-50% and strong: >50% positive tubular cells). Only nuclear 
staining signals were considered positive. 
 
Statistical analysis 








SISH and CISH 
Presence of BK virus DNA was identified by both methods in nuclei of epithelial cells in the 
renal medulla and in cortical renal tubules (Figure 2). The Cleveland cohort was used to compare 
CISH and SISH in 29 renal transplant biopsies clinically suspicious for PVAN. BK-virus DNA 
was detected in five out of 29 cases with the CISH. All of these cases were also positive by BK-
virus SISH. One BK-virus positive SISH patient was CISH negative.  
 
BK-virus SISH and SV40 immunohistochemistry 
The SV40 IHC staining was easy to evaluate in most cases with a distinct nuclear staining 
ranging from weak to strong. The SV40 antigen was detected in more than 50% of the tubules in 
6 out of 26 biopsies. Moderate positivity (25 - 50% of tubules) was seen in 7 biopsies and weak 
positivity (<25% of tubules) in 13 biopsies. 
BK-virus SISH was also positive in all 26 immunohistochemically positive cases. The grading of 
the SISH signal intensity revealed strong positivity in 2 of 26 biopsies, moderate positivity in 3 
biopsies, and weak positivity in 21 biopsies. In comparison to SV40 staining, BK-virus SISH 
displayed more extensive signals in 2 of 26 biopsies (7.7%), equal signal intensity in 6 biopsies 
(23.1%) and weaker signal intensity in the remaining 18 biopsies (69.2%). Nonetheless, the BK-
virus SISH staining intensity was significantly correlated with SV40 staining (p=0.001, 
correlation coefficient 0.631).  In summary, the BK-virus SISH signals were weaker than the 
immunohistochemical staining product. A truly positive signal (e.g. in single cells) was 
sometimes not equivocally discernable from artifacts on the slide, resulting in time-consuming 





Polyomavirus DNA serum levels 
Polyomavirus DNA serum levels as determined by nested PCR analysis were available for 16 of 
the Zurich patients, allowing correlation of BK virus serum levels with staining intensities by SV 
40 immunohistochemistry and BK virus SISH. The median serum levels (closest date to renal 
biopsy) were 574222 copies/ml (range 3287 – 40200000 copies/ml). There were significant 
correlations between the serum virus load and both, the SV40 (p=0.01; correlation coefficient: 
0.513) and the BK-virus SISH (p=0.026; correlation coefficient: 0.455) staining intensity.  
There were 3 patients with JC-virus DNA in the patient’s serum. Only JC virus was present in 
one of these patients. In the other two patients, both JC- and BK-virus DNA were detected in the 
serum. In these 3 patients, staining intensities of SV40 immunohistochemistry and SISH BK 
virus in the tissue were compared. The 2 biopsy samples from the patient with only JC virus 
DNA in the serum were weakly and strongly positive for SV40 (< 25% and > 50% of the tubules, 
respectively). The BK-virus SISH was weakly positive in both biopsies (< 25% of the tubules). A 
subsequent PCR analysis of the biopsy tissue confirmed that only JC virus DNA was present in 
this patient. The two other patients with JC and BK virus DNA in the serum demonstrated weak 
SV40 immunohistochemistry and BK-virus SISH signal intensity (<25% of tubules) with BK-
virus SISH being weaker than SV40 immunostaining. These data suggest potential cross 






In the present study, BK virus DNA was identified in renal biopsies of patients with BK virus 
nephropathy by a novel silver-enhanced in situ-hybridization technology. The results of the study 
indicated good efficacy and robustness of the SISH assay in comparison with CISH and 
immunohistochemistry. 
 
SISH is a recently developed method that offers the advantages of bright field in situ 
hybridization coupled with automation. SISH testing for HER2 gene amplification in breast 
cancer has recently been developed to enable diagnostic laboratories to perform this assessment 
in the routine work process.16-19, 21-23 In breast cancer diagnostics, the SISH approach has 
advantages compared to fluorescence in situ hybridization (FISH). The main problem of FISH is 
represented by the impossibility of archiving the slides because of signal decay. Further, FISH is 
time-consuming and requires the technical infrastructure of a fluorescence microscope. Her2-
SISH has already been suggested as an alternative for the FISH-based Her2 amplification 
analysis in breast cancer patients and has even been successfully tested in cytological 
specimens.20 In these studies, SISH showed a high concordance with FISH and a remarkable 
interobserver reproducibility.16-19, 21, 23 
  
The histologic diagnosis of PVAN in a renal biopsy should be confirmed by a molecular method. 
This is the first study evaluating the SISH technology for BK virus DNA detection in formalin-
fixed paraffin-embedded tissue. According to our data, there is a very high concordance between 
the BK-virus SISH, CISH and conventional SV40 immunohistochemistry for the identification of 




but PCR results should be interpreted with caution. To distinguish productive forms (clinically 
significant) from non-productive latent infections (clinically insignificant) only strong PCR 
signals of BK virus DNA are clinically relevant.26-27 It has been reported that 50% of healthy 
native kidneys and 40% of ureters harbor foci of latent BK virus.28 In addition, PCR is 
technically demanding, does not produce a permanent archival slide and requires specialized 
equipment.  
 
In situ methods, like SISH, CISH or immunohistochemistry allow an unequivocal identification 
of the virus in infected cells compared to conventional H&E morphology with sometimes 
equivocal nuclear changes, especially in tubular regeneration. Interpretation of SV40 
immunohistochemistry was easier than SISH interpretation, due to a higher staining intensity and 
a lower background staining. However, SV40 immunohistochemistry is unspecific and detects all 
viruses of the polyomavirus family. This explains that both cases with JC virus infection and 
absence of BK virus were strongly positive by SV40 immunohistochemistry. Unfortunately, these 
cases also revealed a weak SISH signal. For the SISH assay, a plasmid containing the complete 
BK-virus (BKV) genome (pBKV (35-1) was used, but this probe might have some cross 
reactivity with JC virus. It has been reported that the genome sequence shares 75% homology in 
BK and JC virus, causing this cross reactivity with JC virus.14 Considering the higher costs of in 
situ hybridization techniques in comparison to immunohistochemistry, the BK virus SISH can 
therefore not be recommended as a primary but as an ancillary tool for the assessment of PVAN.   
 
We observed an almost similar sensitivity using CISH and SISH. Recent data suggest that like 
SISH, CISH could be utilized like as a FISH equivalent with comparable accuracy. Automation 




manual protocol. While processing times for CISH and SISH are similar, the BK virus SISH is 
specially designed for automation offering a good integration into laboratory processes. In 
principle, a manually performed BK SISH would be possible if all components of the respective 
kit would be ordered separately. From a practical point of view this is unrealistic and Ventana 
platforms constitute an essential prerequisite for the automated SISH analysis.  
 
We were able to compare BK virus serum levels with the level of BK virus SISH staining in renal 
tissue of PVAN patients. It is well established that high copy numbers of BK virus in the serum 
are a reliable surrogate marker for PVAN.30 Our data show significant correlations of PCR values 
with the quantified histological results.  Nonetheless such correlations could be missing reflecting 
the time difference between serum analyses and biopsies as well as the heterogenic character of 
the disease. In fact, Drachenberg et al. found no direct correlation between level of viremia and 
extent of tissue involvement .31  
 
In conclusion, SISH has a high diagnostic concordance with CISH and SV40 immunostaining, 
fulfils the requirements for diagnostic testing and allows automation. Due to the stable light 
opaque metallic silver signal, SISH can be used with conventional light-microscopy in a setting 
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Figure 1 Illustration of the BK-SISH technology 
A/B: Cell with BK virus DNA integrated in the host cell DNA. C: The host cell DNA is 
degraded. C: The BK virus specific DNA probe with its antibody binding element (green) binds 
to the BK virus DNA in the host cell. D: The primary antibody binds to the binding element of 
the probe. E: The secondary antibodies with the silver elements bind to the primary antibody. F: 
The black silver staining is detectable with conventional light microscopy. 
 
Figure 2 BK-SISH in comparison to the SV40 staining 
A-D Cases with frequent strong specific positivity of SV40 (A/C) and BK-SISH (B/D) in 
corresponding tubules. E/F In the majority of cases the SV40 staining (E) was more frequent and 
easier to detect than the BK virus SISH (F). The only positive nucleus in the BK virus SISH and 
the corresponding one in the SV40 staining are marked with the arrow. Note the other positive 
nuclei in the SV40 staining without a corresponding SISH signal. 
